GPC
40
2
KSS
42
-3
BA
45
-3
CMI
67
4
DUK
50
-2
R
77
2
FTI
78
-3
DTE
38
-4
RSG
77
4
NI
73
3
HPE
70
2
SE
60
-5
CVX
38
6
PSA
58
5
AAPL
45
3
LB
63
-4
LOW
58
2
MU
32
-6
URBN
66
2
SLB
56
-3
GPC
40
2
KSS
42
-3
BA
45
-3
CMI
67
4
DUK
50
-2
R
77
2
FTI
78
-3
DTE
38
-4
RSG
77
4
NI
73
3
HPE
70
2
SE
60
-5
CVX
38
6
PSA
58
5
AAPL
45
3
LB
63
-4
LOW
58
2
MU
32
-6
URBN
66
2
SLB
56
-3
Financhill
Back

P3 Health Partners Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
37

PIII
P3 Health Partners

Last Price:
0.22
Seasonality Move:
-51.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

P3 Health Partners Price Quote

$0.22
-0.03 (-11.96%)
(Updated: November 14, 2024 at 12:40 PM ET)

P3 Health Partners Key Stats

Sell
37
P3 Health Partners (PIII) is a Sell
Day range:
$0.23 - $0.35
52-week range:
$0.30 - $1.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.06
P/B ratio:
0.38%
Volume:
2.7M
Avg. volume:
820.8K
1-year change:
-80.7%
Market cap:
$63.2M
Revenue:
$1.3B
EPS:
$-0.67

How Much Does P3 Health Partners Make?

Is P3 Health Partners Growing As A Company?

  • What Is P3 Health Partners's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.15%
  • What Is P3 Health Partners's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

P3 Health Partners Stock Price Performance

What Is P3 Health Partners 52-Week High & Low?

P3 Health Partners Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy P3 Health Partners?

Is P3 Health Partners Cash Flow Positive?

  • What Is PIII Cash Flow From Operations?
    Cash flow from operations (TTM) is -$53.7M
  • What Is P3 Health Partners’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $66.6M
  • What Is P3 Health Partners’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$175K

P3 Health Partners Return On Invested Capital

  • Is Management Doing A Good Job?
    PIII return on invested capital is -12.43%
  • What Is P3 Health Partners Return On Assets?
    ROA measures how assets are converting to revenues and is -7.87%
  • What Is PIII Return On Equity?
    ROE is a measure of profitability and is -16.7%

P3 Health Partners Earnings Date & Stock Price

P3 Health Partners Competitors

  • Who Are P3 Health Partners's Competitors?
    Below is a list of companies who compete with P3 Health Partners or are related in some way:
    • American Shared Hospital Services (AMS)
    • Astrana Health Inc (ASTH)
    • Biote Corp (BTMD)
    • Cryo-Cell International Inc (CCEL)
    • Omnicell Inc (OMCL)

P3 Health Partners Dividend Yield

P3 Health Partners Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 15.22% -0.77%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 2.70
Upside from Last Price: 980.43%

Major Shareholders

  • How many PIII shares are owned by institutional investors?
    40.1M PIII shares are owned by institutional investors
  • How many PIII shares are owned by insiders?
    6.6M PIII shares are owned by insiders